AXA WORLD FUNDS - Samuel Begasse

Aufstellung des Wertpapierbestands und der sonstigen
Nettovermögenswerte zum 30. Juni 2008 (in USD)
Bezeichnung Anzahl/
Nennwert
Zum offiziellen Börsenhandel zugelassene Wertpapiere
Marktwert % des
Nettover
mögens
CAD Aktien
Shoppers Drug Mart Corp 4,224 232,426 0.70
232,426 0.70
CHF Aktien
Newron Pharmaceuticals Spa 3,621 109,523 0.33
Nobel Biocare Ag 9,450 303,712 0.93
Novartis Ag 8,207 440,947 1.33
Roche Holdings Ag 3,802 652,709 1.97
Schweizerhall Holding Ag 800 171,773 0.52
1,678,664 5.08
DKK Aktien
Novo-Nordisk A/S 5,200 342,629 1.04
342,629 1.04
EUR Aktien
Fresenius Medical Care Ag& 11,689 645,114 1.95
Jerini Ag 5,791 31,833 0.10
676,947 2.05
GBP Aktien
Acambis Plc 121,287 282,009 0.85
Advanced Medical S 365,557 242,069 0.73
Ardana Plc 184,774 23,919 0.07
Corin Group Plc 36,208 115,376 0.35
Hutchison China Me 72,749 177,482 0.54
Lombard Medical Technologies Plc 987,204 191,692 0.58
Osmetech 418,260 137,443 0.42
Prostrakan Group Plc 287,287 454,857 1.38
Shire Ltd 24,139 391,804 1.18
Synergy Healthcare Plc 30,174 445,590 1.35
Tepnel Life Scienc 110,725 0 0.00
Vernalis Plc 603,473 60,693 0.18
2,522,934 7.63
HUF Aktien
Richter Gedeon Veg 2,655 559,153 1.69
559,153 1.69
JPY Aktien
Nichi-Iko Pharmaceutical Co 14,550 359,141 1.08
Sosei Co Ltd 229 88,454 0.27
447,595 1.35
USD Aktien
Alcon Inc 3,809 613,782 1.86
Alexion Pharmaceuticals Inc 8,650 629,634 1.90
Allergan Inc 12,700 655,066 1.98
Allscripts Healthcare Solutions Inc 42,847 546,299 1.65
Altus Pharmaceuticals Inc 42,243 183,335 0.55
Die Erläuterungen im Anhang sind Bestandteil dieses Abschlusses.
Bezeichnung Anzahl/
Nennwert
AXA World Funds - Framlington Health
Marktwert % des
Nettover
mögens
American Medical Systems
Holdings Inc 21,122 315,980 0.96
Amylin Pharmaceuticals Inc 12,069 315,846 0.96
Anesiva Inc 54,313 162,939 0.49
Arthrocare Corp 15,619 650,688 1.97
Barr Laboratories Inc 3,988 179,061 0.54
Biomarin Pharmaceuticals Inc 17,133 514,675 1.56
Brookdale Senior Living Inc 12,992 277,899 0.84
Cardica Inc 36,208 310,665 0.94
Celera Genomics Group-Appler 25,000 291,750 0.88
Celgene Corp 8,650 547,805 1.66
Cephalon Inc 6,949 469,752 1.42
Cerner Corp 7,718 352,713 1.07
Cvs Corp 11,721 466,144 1.41
Davita Inc 11,494 619,067 1.87
Eclipsys Corp 23,980 448,426 1.36
Eli Lilly & Co 9,074 413,865 1.25
Ev3 Inc 24,139 226,907 0.69
Exelixis Inc 24,139 122,868 0.37
Genentech Inc 4,928 358,364 1.08
Gen-Probe Inc 10,500 503,475 1.52
Genzyme Corp - Genl Division 9,407 682,478 2.06
Gilead Sciences Inc 19,045 1,006,719 3.04
Hms Holdings Corp 22,329 486,326 1.47
Hologic Inc 35,000 770,700 2.33
Icon Plc 2,975 229,878 0.70
Indevus Pharmaceuticals Inc 32,530 50,747 0.15
Insulet Corp 19,518 319,510 0.97
Inventiv Health Inc 28,725 805,449 2.44
Kv Pharmaceutical Co-Cl A
Laboratory Corp Of America
12,069 228,466 0.69
Holdings 4,499 311,691 0.94
Medtronic Inc 9,293 476,173 1.44
Merck & Co. Inc. 11,466 424,013 1.28
Meridian Bioscience Inc 12,533 348,919 1.06
Micrus Endovascular Corp 23,415 320,786 0.97
Nuvasive Inc 19,668 880,733 2.66
Nxstage Medical Inc 31,709 128,739 0.39
Onyx Pharmaceuticals Inc 14,900 529,397 1.60
Optimer Pharmaceuticals Inc 24,688 206,145 0.62
Orasure Technologies Inc 50,692 200,233 0.61
Orchid Cellmark Inc 79,669 217,496 0.66
Pdl Biopharma Inc 24,139 254,184 0.77
Phase Forward Inc 18,104 317,725 0.96
Psychiatric Solutions Inc 15,937 607,040 1.84
Sequenom Inc 23,675 361,991 1.09
Sonic Innovations Inc 35,321 107,376 0.32
Spectranetics Corp 28,518 284,610 0.86
Stryker Corp 6,397 398,277 1.20
Thermo Electron Corp 10,343 572,175 1.73
Trans1 Inc 3,200 45,856 0.14
Trizetto Group 20,000 432,200 1.31
Varian Medical Systems Inc 8,449 434,532 1.32
Vnus Medical Technologies Inc 5,764 118,047 0.37
145